BRPI0512874A - composições e métodos para o tratamento de distúrbios inflamatórios - Google Patents

composições e métodos para o tratamento de distúrbios inflamatórios

Info

Publication number
BRPI0512874A
BRPI0512874A BRPI0512874-9A BRPI0512874A BRPI0512874A BR PI0512874 A BRPI0512874 A BR PI0512874A BR PI0512874 A BRPI0512874 A BR PI0512874A BR PI0512874 A BRPI0512874 A BR PI0512874A
Authority
BR
Brazil
Prior art keywords
compositions
inflammatory disorders
treatment
methods
relates
Prior art date
Application number
BRPI0512874-9A
Other languages
English (en)
Inventor
Olga Ignatovich
Rudolf De Wildt
Benjamin Woolven
Steven Grant
Philip Jones
Amrik Basran
Neil Brewis
Original Assignee
Domantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/925,366 external-priority patent/US20050271663A1/en
Priority claimed from US11/098,758 external-priority patent/US20060073141A1/en
Application filed by Domantis Ltd filed Critical Domantis Ltd
Publication of BRPI0512874A publication Critical patent/BRPI0512874A/pt

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

COMPOSIçõES E MéTODOS PARA O TRATAMENTO DE DISTúRBIOS INFLAMATóRIOS. A presente invenção refere-se às composições e métodos para o tratamento de distúrbios inflamatórios. Mais especificamente, a invenção refere-se às composições de anticorpo e seu uso no tratamento de distúrbios inflamatórios.
BRPI0512874-9A 2004-06-30 2005-06-29 composições e métodos para o tratamento de distúrbios inflamatórios BRPI0512874A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB04002829 2004-06-30
US10/925,366 US20050271663A1 (en) 2001-06-28 2004-08-24 Compositions and methods for treating inflammatory disorders
US11/098,758 US20060073141A1 (en) 2001-06-28 2005-04-04 Compositions and methods for treating inflammatory disorders
PCT/GB2005/002553 WO2006003388A2 (en) 2004-06-30 2005-06-29 Compositions and methods for treating inflammatory disorders

Publications (1)

Publication Number Publication Date
BRPI0512874A true BRPI0512874A (pt) 2008-04-08

Family

ID=39262831

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512874-9A BRPI0512874A (pt) 2004-06-30 2005-06-29 composições e métodos para o tratamento de distúrbios inflamatórios

Country Status (1)

Country Link
BR (1) BRPI0512874A (pt)

Similar Documents

Publication Publication Date Title
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
CY1121327T1 (el) Τροποποιημενα αντισωματα anti-il-23p19
ATE469658T1 (de) Kombinationstherapien gegen multiple toll-like- rezeptoren und ihre verwendung
NO20074431L (no) Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer
MX2009006471A (es) Anticuerpo anti especifico de linfopoyetina estromal timica de diseño.
CY1112238T1 (el) Αναστολεις μιτωτικης κινεσινης και μεθοδοι χρησης αυτων
BRPI0506970B8 (pt) derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior
PH12015500248A1 (en) Humanized anti-cxcr5 antibodies, derivatives thereof and their uses
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
BRPI0606891A2 (pt) anticorpos dr5 e usos dos mesmos
CY1112790T1 (el) Χρηση μαγιας σεληνιου στην αντιμετωπιση της νοσου αλτσχαιμερ
BRPI0519424A2 (pt) composiÇÕes e mÉtodos para tratamento de distérbios de proliferaÇço celular
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
BRPI0510094A (pt) uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos
TW200714290A (en) Anti-M-CSF antibody compositions having reduced levels of endotoxin
BR112014018471A2 (pt) anticorpos anti-ige m1' e métodos para o seu uso
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
WO2008150530A3 (en) Cripto binding molecules
TR201818983T4 (tr) İnflamatuvar Cilt Bozukluklarının Tedavisine Yönelik Olarak Sübstitüe Edilmiş Tetrasiklin Bileşikleri
BRPI0511124A (pt) pró-drogas de inibidores de erk proteìna cinase de pirrolilpirimidina
CY1120802T1 (el) Συνθεση
CY1115384T1 (el) Αντι-φλεγμονωδης συνθεση
CY1112121T1 (el) ΠΑΡΑΓΩΓΑ ΤΩΝ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-[1,2-α]-ΠΥΡΑΖΙΝ-6-ΚΑΡΒΟΞΑΜΙΔΙΩΝ ΚΑΙ ΤΩΝ 2,3,4,5-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-(1,2-α)-ΔΙΑΖΕΠΙΝ-7-ΚΑΡΒΟΞΑΜΙΔΙΩΝ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ
WO2006079068A3 (en) Compositions and methods for studying and treating inflammatory diseases and disorders
ATE498010T1 (de) Natürliche igm-antikörper und inhibitoren davon

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.